The OV-Watch® Newsletter Issue 2 May 2006
  First webcast is a big hit
  Dr. Bates conducted OV-Watch's first-ever webcast in March, focusing on specific questions about fertility and conception. With more than 100 participants, we didn't have time to get to all the questions. Register for upcoming webcasts, and be sure to submit your question ahead of time (so we'll be sure to address it).
  • See the March webcast (Click the link at the bottom of the page. Requires audio and a WebEx download, which is provided.)
  • We believe that education about our bodies and monthly cycles is vital to understanding fertility. See the questions and answers that we get or log on and ask Dr. Bates your question.
    Sample Question: How does the OV-Watch compare in accuracy to The Clear Plan Fertility monitor? Have you had 40 and over women report better results with OV-Watch compared to other methods such as Clear Plan? Could the OV-Watch be helpful with a medicated IUI cycle? How might the OV-Watch be more helpful in a medicated IUI cycle than other available monitors? - Carol
    Dr. Bates' Answer: Many women express frustration with the monitors such as Clear Plan Fertility monitor and several have sent me their inaccurate results. Several conditions, including early menopause or decreased function of the ovary and PCOS (polycystic ovarian syndrome), may give false readings due to chronic high LH or estradiol levels. In addition, even if the monitor is accurate, reliance on LH / estradiol levels, cervical mucous, or temperature changes limits many women to hours or a day notice of the approaching ovulation. Timing is especially of the essence as a woman enters her late 30s or early 40s. The OVWatch accurately predicts ovulation and gives a couple 4 or 5 days to achieve conception each month, dramatically reducing the stress of "timed intercourse." Research conducted by fertility specialists at Duke University indicates that the OVWATCH is as good or better than the traditional methods in predicting a woman's fertility and was almost 6 times more likely to predict a 4- or 5-day window of opportunity. The OVWatch can also be used to determine if ovulation is occurring spontaneously and to accurately predict the fertility window in women on clomiphene citrate. Accurate determination of ovulation and early consultation with a fertility specialist are of paramount importance when a woman wishes to become pregnant in her later reproductive years.
  • Register for an upcoming conference

In this Issue
Webcast
Lead Story
Fertility Specialist
Invite a Friend
Feedback
Latest News



LEAD STORY   The age-fertility connection
 

Since the 1970s, the rate of women having their first baby while in their 20s has dropped by 30%. Approximately 20% of American women now give birth for the first time after age 35. And, with more than 15% of couples having difficulty conceiving, it's no surprise that information about age and fertility - including misinformation - is prevalent.    Read the full story

RELATED LINKS:

   ASK THE FERTILITY SPECIALIST
 


G. Wright Bates, Jr., M.D., has lectured widely on fertility related issues, including ovulation and practices at the Atlanta Center for Reproductive Medicine. He is board certified in OB/GYN, as well as Reproductive Endocrinology. He has served as OB/GYN faculty and Director of In Vitro Fertilization at Wilford Hall Medical Center in San Antonio, TX.

  Ask Dr. Bates a question about your fertility.
 		  

   INVITE A FRIEND
 

Please share this issue of Baby Steps with any friends who would be interested. Simply fill in the information, and we'll send a copy to them. We promise not to send anything else unless they request it.

 		  

   FEEDBACK
 

If you've got a comment on the newsletter or an idea for a story, please share it with us. Chances are that if you'd like to read about a particular topic, others would, too.
 		  

See the latest OV-Watch news clips
 

OV-Watch made the national news on Sunday, April 9. Dr. G. Wright Bates was interviewed on the Fox & Friends morning program (Fox News Channel) about the exciting clinical data from Duke comparing OV-Watch to LH urine tests.

View the video clip


See other OV-Watch news clips
  

SPECIAL NOTE: Please add us to your list.
To make sure you never miss an issue of Baby Steps, please add mailmngr_nws@ovwatch.com to your "good" list.

Examples of e-mail "good" lists:
  •    AOL 9.0: Address Book
  •    HotMail: Safe List
  •    Yahoo: Add to your address book. If you find it in the bulk mail folder, click on the "This is not spam"
       link, and subsequent issues will come to your inbox.
  •    Some spam filters: Whitelist
Baby Steps from OV-Watch is a free, subscription-based e-mail from OV-Watch in Sarasota, Florida. If you'd prefer
not to receive this newsletter, click the "unsubscribe" link below.

Copyright 2006 HealthWatchSystems, Inc. All rights reserved.

Privacy policy  •  Subscribe  •  Unsubscribe